Literature DB >> 11242151

Mutations in HIV-1 gag cleavage sites and their association with protease mutations.

N Koch1, N Yahi, J Fantini, C Tamalet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11242151     DOI： 10.1097/00002030-200103090-00013

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease.

Authors:  Deborah S Dauber; Rainer Ziermann; Neil Parkin; Dustin J Maly; Sami Mahrus; Jennifer L Harris; Jon A Ellman; Christos Petropoulos; Charles S Craik
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  The choreography of HIV-1 proteolytic processing and virion assembly.

Authors:  Sook-Kyung Lee; Marc Potempa; Ronald Swanstrom
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

3.  Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection.

Authors:  Mark A Brockman; Zabrina L Brumme; Chanson J Brumme; Toshiyuki Miura; Jennifer Sela; Pamela C Rosato; Carl M Kadie; Jonathan M Carlson; Tristan J Markle; Hendrik Streeck; Anthony D Kelleher; Martin Markowitz; Heiko Jessen; Eric Rosenberg; Marcus Altfeld; P Richard Harrigan; David Heckerman; Bruce D Walker; Todd M Allen
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

4.  Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.

Authors:  Sarah K Ho; Elena E Perez; Stephanie L Rose; Roxana M Coman; Amanda C Lowe; Wei Hou; Changxing Ma; Robert M Lawrence; Ben M Dunn; John W Sleasman; Maureen M Goodenow
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

5.  Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1.

Authors:  Lay Myint; Masakazu Matsuda; Zene Matsuda; Yoshiyuki Yokomaku; Tomoko Chiba; Aiko Okano; Kaneo Yamada; Wataru Sugiura
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.